Recently, Hedberg et al1 identified a DES mutation (p.P419S) in a Swedish family, suffering from myofibrillar myopathy (MFM) in combination with arrhythmogenic right ventricular cardiomyopathy (ARVC), by next-generation sequencing. Originally, a linkage analysis indicated that the genetic defect is located on chromosome 10q22.3 in this family.2 The analysis of muscle biopsies of affected patients demonstrated an aggregation of desmin and further proteins.
The same desmin mutation (p.P419S) was identified before by Olivé et al3 in patients suffering from skeletal myopathy or hypertrophic cardiomyopathy, respectively. However, Hedberg et al1 demonstrated that this mutation did not completely co-segregate within the Swedish family, raising the questions on pathogenesis or penetrance, respectively. Of note, in both studies the desmin mutant p.P419S was not functionally characterized. Hence, it is currently difficult to judge the pathological potential of this variant. Especially, it is unclear whether the DES mutation p.P419S is a sufficient molecular trigger for aggregate formation.
For this reason, we introduced this mutation by site-directed mutagenesis into a desmin construct (pEYFP-N1-Desmin) using appropriate oligonucleotides and transfected H9c2, C2C12 and SW-13 cells with mutant and wild-type desmin–eYFP constructs. The filament or aggregate formation was investigated in cell culture and the filament formation of purified recombinant mutant desmin was analysed in vitro by atomic force microscopy (AFM), as previously described.4
To our surprise, the expression of desmin-p.P419S does not induce an aggregation in either cell line as recently described for other ARVC-related desmin mutants4, 5, 6 (Figure 1). The cell culture data were also supported by the AFM analysis virtually yielding undistinguishable desmin filaments between wild-type and desmin-p.P419S in vitro (Figure 2). Thus, our data reveal that the desmin mutant p.P419S published by Hedberg et al1 forms filaments in vitro and in transfected cells. Consequently, it might be important to look for further molecular triggers, which induce or influence the protein aggregation in the Swedish patients suffering from MFM/ARVC. From our point of view, the next-generation sequencing data of Hedberg et al1 might provide an important basis for further studies, identifying modifier genes or other molecular abnormalities responsible for desmin aggregate formation.
References
Hedberg C, Melberg A, Kuhl A, Jenne D, Oldfors A : Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation. Eur J Hum Genet 2012; 20: 984–985.
Melberg A, Oldfors A, Blomstrom-Lundqvist C et al: Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 1999; 46: 684–692.
Olivé M, Armstrong J, Miralles F et al: Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord 2007; 17: 443–450.
Brodehl A, Hedde PN, Dieding M et al: Dual-color photoactivation localization microscopy of cardiomyopathy associated desmin mutants. J Biol Chem 2012; 287: 16047–16057.
Klauke B, Kossmann S, Gaertner A et al: De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet 2010; 19: 4595–4607.
Vernengo L, Chourbagi O, Panuncio A et al: Desmin myopathy with severe cardiomyopathy in a Uruguayan family due to a codon deletion in a new location within the desmin 1A rod domain. Neuromuscul Disord 2010; 20: 178–187.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Brodehl, A., Dieding, M., Cakar, H. et al. Functional characterization of desmin mutant p.P419S. Eur J Hum Genet 21, 589–590 (2013). https://doi.org/10.1038/ejhg.2012.212
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejhg.2012.212
This article is cited by
-
Molecular insights into cardiomyopathies associated with desmin (DES) mutations
Biophysical Reviews (2018)
-
Reply to Brodehl et al
European Journal of Human Genetics (2013)